Litcius/Paper detail

The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis

Eric L. Simpson, Robert Bissonnette, Lawrence F. Eichenfield, Emma Guttman‐Yassky, Brett King, Jonathan I. Silverberg, Lisa A. Beck, Thomas Bieber, Kristian Reich, Kenji Kabashima, Marieke M.B. Seyger, Elaine C. Siegfried, Georg Stingl, Steven R. Feldman, Alan Menter, Peter van de Kerkhof, Gil Yosipovitch, C. Paul, Philippe Martel, Ariane Dubost-Brama, John Armstrong, Rajeev Chavda, Steve Frey, Y. Joubert, M. Milutinovic, Anne Parneix, Henrique D. Teixeira, Chen-Yen Lin, Luna Sun, Paul Klekotka, Brian J. Nickoloff, Yves Dutronc, Lotus Mallbris, Jonathan Janes, Amy M. DeLozier, Fabio P. Nunes, Amy S. Paller

2020Journal of the American Academy of Dermatology178 citationsDOI

Topics & Concepts

Atopic dermatitisMedicineReliability (semiconductor)DermatologyQuantum mechanicsPhysicsPower (physics)Dermatology and Skin DiseasesAsthma and respiratory diseasesPsoriasis: Treatment and Pathogenesis
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis | Litcius